Navigation Links
Cynthia Haines, M.D., Named Managing Editor of Physician's Briefing News Wire
Date:10/22/2007

NORWALK, Conn., Oct. 22 /PRNewswire/ -- Dr. Cindy Dennison Haines has been named Managing Editor of HealthDay's Physician's Briefing, a daily news service for health and medical professionals.

"We're delighted to have Cindy take the leading role in managing Physician's Briefing's editing and writing team," said Editor-in-Chief Barry Hoffman, who oversees both the professional news service and HealthDay, a leading daily health news service for consumers. "Her knowledge of important medical issues and research into diseases helps the daily news on our Physician's Briefing wire pinpoint those topics that health professionals will find particularly compelling."

Dr. Haines, 36, a family physician, is on staff at St. John's Mercy Medical Center and an assistant clinical professor at Saint Louis University's School of Medicine in the Department of Community and Family Medicine.

Before joining Physician's Briefing full time, Dr. Haines ran her own medical communications consulting firm and has been a medical writer, senior medical editor and consultant to both consumer and professional healthcare content providers.

She earned her Bachelor of Science degrees in biology and psychology from Saint Louis University. She also studied medicine at Saint Louis University School of Medicine and earned an M.D. with Distinction, as well as a Geriatric Scholar's Award.

Dr. Haines is a member of the American Academy of Family Physicians and is board certified in Family Medicine. She is also active in the St. Louis business and health community, serving as vice president of the board for the Saint Louis Academy of Family Physicians and director of marketing and publicity for the Healthcare Businesswomen's Association (St. Louis chapter).

Physician's Briefing is a division of ScoutNews, LLC, a Norwalk, Conn.- based news and information company.

The news service provides timely and concise summaries from peer-reviewed medical journals and sen
'/>"/>

SOURCE HealthDay
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Bruce Maas named CIO at UW-Milwaukee
2. Three finalists named for UW-Madison CIO
3. Eight lawmakers named to Speakers IT task force
4. Hospital named for Madame Curie installs TomoTherapy system
5. Two UW-Madison professors named to National LambdaRail Networking Research Council
6. UW researcher named top innovator
7. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
8. Inacom named Microsofts favorite learning solutions partner of the year
9. Five Wisconsin CIOs named top in nation
10. Deltanoid named to top-15 list of biotech companies
11. Managing the nightmare of identity theft
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
(Date:1/14/2014)... OTTAWA, Ontario , Jan. 14, 2014   Kinaxis ®, ... ( SCM ) and sales and operations planning ( S&OP ... the Biomanufacturing Summit , which will be held at ...  At the conference, join Kinaxis customer Elisabeth Kaszas , ...
(Date:1/14/2014)... Kerr Corporation, a leading manufacturer of innovative dental ... about dual arch impressions on its dental blog. ... blog entry serves up a list of tips to help ... by Dr. David Little as he crafts a porcelain crown ...
(Date:1/14/2014)... 2014 Independent publisher Bitingduck Press, with ... Canada, has big ideas for 2014 in production and ... are to produce high-quality, low-cost, DRM-free ebooks and to ... , The first major development will be bookstore ...
Breaking Biology Technology:RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... the Netherlands, February 24 ,Amsterdam Molecular Therapeutics (Euronext: AMT), a leader ... the year of 2008. , Highlights, ... delay of the announced, filing date ... - Positive clinical data on GlyberaTM, ...
... SPRINGS, Colo., Feb. 23 The National Academy of ... 2009 finds deficiencies in the nation,s forensic science system ... The report also calls for the development of accreditation ... a code of ethics for experts in all aspects ...
... 23 Texcel Medical, LLC, a full service ... company, has announced the appointment of Barry ... functions at Texcel Medical , which helps ... infrastructure and expertise they need to accelerate the ...
Cached Biology Technology:Amsterdam Molecular Therapeutics Reports Full Year Results 2008 2Amsterdam Molecular Therapeutics Reports Full Year Results 2008 3Strengthening Forensic Toxicology in the United States: The American Board of Forensic Toxicology Response to the National Academy of Sciences Recommendations 2Texcel Medical Appoints Barry Smith as President, CEO 2
(Date:7/9/2014)... that can attack soybean crops, why would charcoal rot ... University of Illinois scientists cite the earth,s changing climate ... the fungus that causes charcoal rot. , Fungi may ... Macrophomina phaseolina , the fungus that causes charcoal ... the climate continues to change and we see more ...
(Date:7/9/2014)... shows that the population is 3.79 million breeding ... Adlie penguins have long been considered a key ... of climate change and fishing in the Southern ... from Stony Brook University and University of Minnesota ... monitoring of Adlie penguins across their entire breeding ...
(Date:7/9/2014)... candidate developed by researchers at the NIH,s ... and its collaborators to treat sickle cell ... BioScience business. The drug candidate, Aes-103, is ... underlying molecular mechanism of sickle cell disease. ... activities required for regulatory approval and commercialization. ...
Breaking Biology News(10 mins):Climate change provides good growing conditions for charcoal rot in soybeans 2Climate change provides good growing conditions for charcoal rot in soybeans 3New study finds that Adélie penguin population is on the rise 2New study finds that Adélie penguin population is on the rise 3First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4
... with intellectual and developmental disabilities living in family ... routine dental care than those living in institutions, ... associate professor Catherine Binkley, D.D.S., Ph.D. These individuals ... to have poor oral hygiene, increased decay and ...
... shows that following a vegetarian diet and exercising at least ... in African Americans, who are twice as likely to be ... "These findings are encouraging for preventing type 2 diabetes ... disease than other populations," said Serena Tonstad, MD, a professor ...
... called "the trots," "Montezuma,s Revenge," "the runs" and worse. But ... a medicine that could go straight to the offending bacteria ... come true if work by Texas A&M University scientists stays ... Station. A "medicine that grows" is how the phage ...
Cached Biology News:UofL researcher to develop oral health plan for those with IDD 2Vegetarian diet, physical activity protect against diabetes in black population, study shows 2Texas A&M center confronts antibiotic crisis with potential new bacterial treatment 2Texas A&M center confronts antibiotic crisis with potential new bacterial treatment 3Texas A&M center confronts antibiotic crisis with potential new bacterial treatment 4
...
These 22x40mm rectangular No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick. • Approx. Pcs Oz : 73...
... Experion software, PC, is used to ... data obtained from the Experion automated ... in electropherogram and simulated gel views ... calculations in a Results table. This ...
...
Biology Products: